CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Arcadia Biosciences, Inc.

RKDA
$2M
Micro Cap
NASDAQCrude Petroleum & Natural Gasagricultural biotechnology🇺🇸North AmericaDALLAS9 employees

Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

RKDA News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How RKDA's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Arcadia Biosciences, Inc.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Arcadia Biosciences, Inc. (RKDA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track RKDA biotech catalysts?

Add RKDA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Arcadia Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply